Tech Company Financing Transactions
Actimis Pharmaceuticals Funding Round
On 6/30/2008, Actimis Pharmaceuticals secured $9.6 million in funding from Sanderling Ventures and private investors.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$9,600,000
Round
Undisclosed
Investors
Sanderling Ventures (Fred Middleton)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10835 Road to the Cure 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Kevin Bacon
Browse more venture capital transactions:
Prev: 6/30/2008: Axiom Microdevices venture capital transaction
Next: 6/30/2008: Spring2 Partners venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs